2.1. Study Design and Participants
hereditary breast and ovarian cancer
SECONDARY
The present study is a cross-sectional secondary analysis of the baseline data from the randomized controlled LIBRE-2 trial (a lifestyle intervention study in women with hereditary breast and ovarian cancer) and the associated feasibility study LIBRE-1 [